Skip to content

Psycho-Oncology & Quality of Life

Note: This page is educational and reflects the state of the literature in 2025. It does not replace medical or psychological advice.

TL;DR

Psycho-oncology is the multidisciplinary field that addresses the psychological, social, and behavioral dimensions of cancer — for patients, families, and clinicians. Roughly 30–40 % of cancer patients experience clinically significant distress at some point. Modern oncology guidelines treat distress screening as a 6th vital sign, alongside symptom management. Effective interventions exist (CBT, mindfulness, group support, pharmacotherapy, exercise, palliative integration) but access — especially in Brazil — remains uneven.


1. Why psycho-oncology matters

Cancer is a stressor unlike most others — life-threatening, prolonged, with treatments that themselves impose physical and psychological burden. Specific challenges:

  • Existential distress — diagnosis as a confrontation with mortality.
  • Treatment burden — surgery, chemo, radiation, immunotherapy fatigue and side effects.
  • Body image and identity — mastectomy, ostomy, alopecia, sexual function changes.
  • Caregiver and family strain — caregiving morbidity is real and measurable.
  • Pediatric and young-adult specifics — interrupted development, education, fertility.
  • Survivorship — fear of recurrence, post-treatment uncertainty, return to work.
  • End-of-life — dignity, decision-making, advance directives, palliative integration.
  • Healthcare team distress — moral injury, burnout in oncology professionals.

Distress is not weakness; it is a predictable response to a hard situation. Treating it improves quality of life and, in many studies, adherence and outcomes.


2. Common conditions

ConditionNotes
Adjustment disorderMost common — reaction to diagnosis or treatment
Major depressive disorder~15–25 % prevalence in cancer; underdiagnosed
Generalized anxiety, panicProcedural anxiety, fear of recurrence common
Post-traumatic stress (PTSD)Diagnosis or treatment as traumatic event; ~10–20 % at some point
Demoralization syndromeLoss of meaning, hopelessness without full depression
DeliriumEspecially advanced disease, opioids, metabolic causes
Sleep disorders, insomniaVery common; underestimated
Sexual dysfunctionVery common, rarely addressed proactively
Cognitive changes ("chemo brain")Subjective and objective domains; under-researched
Bereavement (caregivers)Anticipatory and post-loss; complicated grief

3. Distress screening — the "6th vital sign"

The NCCN Distress Thermometer (0–10 visual analog plus problem checklist) and the PHQ-9, GAD-7, and HADS are widely used in cancer settings. Screening should:

  • Happen at diagnosis, transitions of care, and survivorship.
  • Trigger a clear referral pathway when above threshold.
  • Be paired with cultural, language, and literacy adaptation.
  • Be more than checkbox compliance — actual response matters.

In Brazil, NCCN-translated screening tools are available; uptake varies by service.


4. Interventions that work

Evidence base summarized from systematic reviews: Sources: [1], [2]

Psychological / behavioral

  • Cognitive Behavioral Therapy (CBT) — depression, anxiety, insomnia, fear of recurrence; strongest evidence base.
  • Mindfulness-Based Stress Reduction (MBSR) — distress, fatigue, sleep.
  • Acceptance and Commitment Therapy (ACT) — meaning, values, distress.
  • Meaning-Centered Psychotherapy — advanced disease, demoralization.
  • Couples and family therapy — communication, caregiving, intimacy.
  • Group support — connection, normalization, shared coping.
  • Psychoeducation — informed coping, side-effect anticipation.

Lifestyle and behavioral

  • Aerobic and resistance exercise — fatigue (best evidence), depression, QoL. Sources: [2]
  • Yoga, tai chi — fatigue, sleep, mood.
  • Sleep hygiene + CBT-I for insomnia.
  • Nutrition and weight management — survivorship outcomes.

Pharmacotherapy

  • SSRIs / SNRIs — depression, anxiety; consider drug interactions (tamoxifen + paroxetine, etc.).
  • Mirtazapine — depression with anorexia / insomnia.
  • Methylphenidate — fatigue, cognitive symptoms (mixed evidence).
  • Benzodiazepines — short-term anxiety, procedural; not first-line for chronic anxiety.
  • Atypical antipsychotics — delirium.
  • Dexamethasone — fatigue near end-of-life (short-term). Sources: [2]

Telehealth and remote support

  • Telephone interventions show benefit for depression, anxiety, and emotional distress, with reasonable certainty. Sources: [1]
  • Web-based CBT and app-delivered support — growing evidence base, especially for younger patients.

5. Specific scenarios

Newly diagnosed

  • High distress; information overload; decision-making support.
  • Brief psycho-education + accessible team contact often sufficient.

Active treatment

  • Symptom management (fatigue, nausea, pain), social support, treatment adherence.
  • Procedural anxiety (chemo, scans) responds well to brief CBT and pharmacological support.

Advanced disease and palliative care

  • Goal-of-care conversations, advance directives.
  • Existential distress and demoralization respond to meaning-centered approaches.
  • Integrated palliative care (early — at diagnosis of advanced disease, not "end of options") improves QoL and survival in some trials.

Survivorship

  • Fear of recurrence is the most common ongoing concern; cognitive symptoms, fatigue, sexual function under-addressed.
  • Survivorship care plans (treatment summary + follow-up plan + late-effect surveillance) are evolving standard of care.

Pediatric

  • Family-centered; school re-integration; developmental considerations.
  • See Pediatric oncology.

Caregivers and bereavement

  • High morbidity in caregivers; psychological support during AND after.
  • Complicated grief affects ~10–20 %; specific therapies exist.

6. Brazilian context

  • Sociedade Brasileira de Psico-Oncologia (SBPO) organizes the field; certification and training pathways exist.
  • Psycho-oncology services are concentrated in tertiary centers (A.C. Camargo, INCA, GRAACC, Hospital Sírio-Libanês, Albert Einstein, ICESP, Hospital de Câncer de Barretos, Hospital Pequeno Príncipe, etc.).
  • SUS coverage of psychological care for oncology patients is uneven; community-based programs and partnerships with universities help fill gaps.
  • Religious and spiritual support plays a culturally significant role in Brazilian patient coping; integration into psycho-oncological services is expanding.
  • Telehealth psycho-oncology grew significantly post-2020 and remains a major access lever for patients outside major capitals.

7. What technology can contribute

  • Distress screening at scale — embedded in EHR/portal workflows with thresholded referrals.
  • ePROs and remote monitoring — early detection of deteriorating symptoms (depression, pain, fatigue).
  • CBT/MBSR content delivery — apps and web-based programs validated for cancer populations.
  • Caregiver tools — coordination, respite scheduling, peer support.
  • Survivorship-care-plan generators — auto-populated from treatment data.
  • Conversational AI — well-designed it can complement (not replace) human support; poorly designed it reinforces avoidance.
  • Equity — language, literacy, and accessibility considerations central, not afterthought.

See also


References

  1. Ream E, Hughes AE, Cox A, et al. Telephone interventions for symptom management in adults with cancer. Cochrane Database Syst Rev 2020;6:CD007568. PMID 32483832. https://doi.org/10.1002/14651858.CD007568.pub2
  2. Stone P, Candelmi DE, Kandola K, et al. Management of Fatigue in Patients with Advanced Cancer. Curr Treat Options Oncol 2023;24:93-107. PMID 36656503. https://doi.org/10.1007/s11864-022-01045-0
  3. U.S. National Cancer Institute. Coping with cancer. https://www.cancer.gov/about-cancer/coping
  4. American Cancer Society. Coping with cancer. https://www.cancer.org/cancer.html
  5. Cleveland Clinic. Cancer (overview). https://my.clevelandclinic.org/health/diseases/12194-cancer
  6. Sociedade Brasileira de Psico-Oncologia (SBPO). https://www.sbpo.org.br/
  7. A.C. Camargo Cancer Center. https://accamargo.org.br
  8. Fundação do Câncer (Brasil). https://www.cancer.org.br/
  9. Ministério da Saúde / BVS. ABC do câncer. https://bvsms.saude.gov.br/bvs/publicacoes/abc_do_cancer.pdf
  10. Instituto Nacional de Câncer (INCA). https://www.inca.gov.br/

Early public release. Content evolves through continuous review. Questions: [email protected] · CC BY 4.0 where applicable.